Medication info

Amiral Inj

Prescription medicationInjectionApproval withdrawn
Ingredient · strength
L-Lysine Hydrochloride›350mg / 100mLL-Isoleucine›220mg / 100mLL-Leucine›330mg / 100mLL-Methionine›200mg / 100mLL-Phenylalanine›220mg / 100mLL-Threonine›200mg / 100mLL-Tryptophan›90mg / 100mLL-Valine›280mg / 100mLGlycine›380mg / 100mLL-Alanine›380mg / 100mLL-Arginine›500mg / 100mLL-Proline›370mg / 100mLL-Serine›370mg / 100mLL-Tyrosine›50mg / 100mLL-Histidine Hydrochloride Hydrate›138mg / 100mLL-Ornithine Hydrochloride›126mg / 100mLL-Aspartic Acid›570mg / 100mLL-Glutamic Acid›350mg / 100mLXylitol›5000mg / 100mLD-Sorbitol›5000mg / 100mL
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
The product is a colorless or pale yellow transparent aqueous injection.
Packaging
For internal use - 500 milliliters per package
Approval status
Approval withdrawn

MFDS item code 198500308 · Notified 1985.04.02 · Insurance code 645400662

This product's status changed to Approval withdrawn on 2025.07.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of nutritional status through amino acid supplementation (for hypoproteinemia, malnutrition, etc.)
Who receives it
Adults · Children
Adult administration
○Adults: Administer by intravenous infusion, with a maximum dose of 1~1.5 g per kg of body weight per day as total amino acids. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; as a rule, infuse at a rate of 80~130 drops per minute. However, the maximum daily dose is 100g as D-sorbitol.
Child administration
In children, elderly patients, and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of nutritional status through amino acid supplementation (for hypoproteinemia, malnutrition, etc.)

  • Hypoproteinemia
  • malnutrition
View approved original text

Amino acid supplementation is needed in cases of hypoproteinemia, malnutrition, and situations such as before and after surgery. In these conditions, protein synthesis in the body may decrease or be lost, so appropriate amino acid supplementation is required to improve nutritional status and assist in recovery. Amino acid supplementation is used to improve hypoproteinemia and enhance overall nutritional status.

How it is given

Adult administration

○Adults: Administer by intravenous infusion, with a maximum dose of 1~1.5 g per kg of body weight per day as total amino acids. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; as a rule, infuse at a rate of 80~130 drops per minute. However, the maximum daily dose is 100g as D-sorbitol.

Child administration

In children, elderly patients, and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.

Precautions

This medication must be used according to a doctor's instructions and should not be taken arbitrarily based on personal judgment. It should not be administered to patients at risk of hepatic coma or with severe liver dysfunction, patients with severe kidney impairment, and patients with certain metabolic disorders. Patients with severe heart failure or pulmonary edema, those with very little or no urine output, and patients with hypernatremia or hyperchloremia should also avoid using this medication. If certain components are included, it should be avoided in patients with lactic acidosis, methanol poisoning, hereditary fructose intolerance, heart block, or severe myasthenia gravis. This medication should be used with caution in patients with severe acidosis, congestive heart failure, edema due to sodium retention, hyperkalemia, and those with impaired liver or kidney function should be observed closely. Some components in this medication may cause allergic reactions, particularly anaphylaxis or asthma attacks, so asthmatic patients should be especially cautious. Various side effects may appear during administration, such as rash, nausea, vomiting, palpitations, increased blood pressure, so any unusual symptoms should be reported to medical personnel immediately. Rapid administration of large amounts may lead to acidosis, so the rate and amount of administration must be strictly managed. Patients with kidney disease, lung disease, or heart disease should avoid excessive fluid administration, and diabetic patients should frequently monitor blood glucose levels. There may be interactions with other medications, so if you are taking other medications, you must inform medical personnel. Pregnant women should use this medication cautiously only when absolutely necessary, as its safety has not been fully established. When administered to children or elderly patients, dosage and infusion rates should be adjusted to reduce the risk of side effects. This medication contains electrolytes, so care should be taken with electrolyte balance, and it should be infused slowly into the vein during administration. To reduce the risk of infection during administration, maintain strict aseptic conditions and do not use if the solution is discolored or abnormal. If certain components are included, the rate and amount of administration must be strictly limited to prevent kidney or liver damage. Lastly, this medication is not safe to use in patients with a history of myocardial infarction.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • tachycardia
  • hypertension
  • acidosis
  • warmth
  • vascular pain
Show 29 more
  • chills
  • fever
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • ureteral spasm
  • peripheral vascular dilation
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes mellitus
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • childhood hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air and is best stored at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy and allow for safe use.

Appearance and packaging

Appearance

The product is a colorless or pale yellow transparent aqueous injection.

Package unit

For internal use - 500 milliliters per package

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.